Fundraising Fox

Raju Kucherlapati

Investor

Venture Partner at Catalio Capital Management, LP

Weston, Florida

Writes $100K – $5M checks · typically $1.5M

About

Raju Kucherlapati is a Professor of Genetics at Harvard Medical School. He earned his PhD from the University of Illinois Urbana-Champaign and completed postdoctoral training at Yale University, following degrees earned in India. He was elected to the National Academy of Medicine and served on the Presidential Commission for the Study of Bioethical Issues from 2009 to 2017.

Invests in

Biotech

Experience

  1. Harvard Medical SchoolProfessorcurrent2001 — present
  2. Harvard Medical SchoolProfessorcurrent2001 — present
  3. KEW GroupFounder and member BODcurrent2010 — presentGreater Boston Area
  4. Brigham and Women's HospitalProfessor of Medicinecurrent2001 — present
  5. PureTech HealthMember, BODcurrent2014 — presentBoston, Massachusetts, United States
  6. PureTech HealthMember, BODcurrent2014 — present
  7. PureTech HealthMember, BODcurrent2014 — present
  8. Metamark GeneticsMember, Board of Directors2009 — 2021Cambridge, MA
  9. AVEO PharmaceuticalsMember, Board of Directors2002 — 2021
  10. AACRmember2008 — 2015
  11. Enlight BiosciencesMember BOD2008 — 2010
  12. Harvard Partners Center for Genetics and GenomicsScientific Director2001 — 2008
  13. Millennium PharmaceuticalsMember, Board of Directors1993 — 2008
  14. AbgenixMember, Board of Directors1996 — 2006
  15. Albert Einstein College of MedicineProfessor1989 — 2001
  16. Albert Einstein College of MedicineSaul and Lola Kramer Professor and University Chairman1989 — 2001
  17. University of Illinois College of MedicineProfessor1982 — 1989
  18. Princeton UniversityAssistant Professor1975 — 1982

Education

  1. Yale UniversityFellow, Genetics1972 — 1975
  2. University of Illinois Urbana-ChampaignPhD, Genetics1967 — 1972

Skills & more

Cancer99Lifesciences46Molecular Biology91Drug Discovery56Cell Biology43Biotechnology61Clinical Development15Biochemistry43Oncology30Clinical Trials18Technology Transfer13Pharmaceutical Industry18
+4 moreClinical ResearchBioinformaticsGenomicsFDA

Languages English

From Raju's professional profile.

Investments

Board seats

AbgenixAVEO PharmaceuticalsCell GenesysGelesisKEW, Inc.Millennium PharmaceuticalsPureTech Health

Per the firm's website.

Colleagues at Catalio Capital Management, LP

Adam Riess
Venture Partner at Catalio Capital Management, LP
Alan Ashworth
Venture Partner at Catalio Capital Management, LP
Christine E. 'Kricket' Seidman
Venture Partner at Catalio Capital Management, LP
Dan Littman
Venture Partner at Catalio Capital Management, LP
David Sinclair
Venture Partner at Catalio Capital Management, LP
Diamantis Xylas
Analyst at Catalio Capital Management, LP
Frances H. Arnold
Venture Partner at Catalio Capital Management, LP
Freda Lewis-Hall
Venture Partner at Catalio Capital Management, LP

Frequently asked questions

Where does Raju Kucherlapati work?
Raju Kucherlapati is Venture Partner at Catalio Capital Management, LP.
What does Raju Kucherlapati invest in?
Raju Kucherlapati invests in Biotech.
What check size does Raju Kucherlapati write?
Raju Kucherlapati typically writes checks of $100K – $5M.

Founder mafias

Yale University mafia182

Also came through, then founded or led a company.

Michael SeibelBAFounded SocialCamJustin KanPhysics and PhilosophyFounded Rye +5Kevin RyanBAFounded Business Insider +2Harry GrunerFounded Hilos +2Emmett ShearBSFounded Softmax +2Jake SchwartzBachelor of Arts (B.A.)Founded Brave Health +1

+ 175 more

University of Illinois Urbana-Champaign mafia143

Also came through, then founded or led a company.

Ansuman SatpathyPhilosophyFounded Santa Ana Bio +2DeVaris BrownB.S.Founded Super Heroic +2Harish AgarwalB.S.Founded Nori +2Amitt MahajanBSFounded Rare Bits +1Maria FardisB.S.Founded Airnexis Therapeutics Inc +1Dan KazanBSFounded Rewards Network +1

+ 136 more

Catalio Capital Management, LP mafia5

Also came through, then founded or led a company.

Sangeeta N. BhatiaVenture PartnerFounded Port Therapeutics +3Frances H. ArnoldVenture PartnerFounded ProviviJim J. CollinsVenture PartnerFounded Sherlock BiosciencesSamir MitragotriVenture PartnerFounded i2O Therapeutics

PureTech Health mafia2

Also came through, then founded or led a company.

David SteinbergCo-Founder and Chief Innovation OfficerFounded Restorbio +1

Same school

Also attended Yale University619

Ann Miura-KoCo-founding Partner at FloodgateDavid SzeAdvisory Partner at GreylockMichael SeibelPartner Emeritus at Y CombinatorZheela QaiserInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)

+ 613 more

Also attended University of Illinois Urbana-Champaign392

Sundeep PeechuGeneral Partner at Felicis VenturesDeep NisharInvestment Team at General CatalystPrashant ShahPartner at Monta Vista CapitalNoorPartner at Clear VenturesPaul BragielCo-founder at Golden Gate VenturesGreg RudinBoard Partner at Menlo Ventures

+ 386 more

Shared employers

Also worked at Harvard Medical School162

Logan HilleLife Sciences Analyst at CincyTechAnkit GuptaGeneral Partner at Y CombinatorDavid MollerInvestor at Third Rock VenturesJulie YangInvestor at Third Rock VenturesTracy WilliamsInvestor at Third Rock VenturesSamuel ArbesmanVenture Partner at Lux Capital

+ 156 more

Also worked at Abgenix1

Chris PeetzEntrepreneur-in-Residence at Frazier Life Sciences

Also worked at Albert Einstein College of Medicine2

Barry SteinVice President, Chief Clinical Innovation Officer and Chief Medical Informatics Officer at Flare Capital PartnersCaitlin SwiftFounder at Clara

Also worked at University of Illinois College of Medicine6

Gordon RausserAdvisory Board Member at Rembrandt Venture PartnersJohn MathenyVenture Partner at Foothill VenturesMichael BurrowsFinance Advisor at 2Flo VenturesChristopher ValeraOperations Coordinator at Illinois VenturesDr. Susan A. MartinisVice Chancellor for Research and Innovation, University of Illinois Urbana-Champaign at Illinois VenturesDr. Jay WalshVice President for Economic Development and Innovation, University of Illinois at Illinois Ventures